Results 31 to 40 of about 116,971 (308)

Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Pulmonary embolism (PE) has a long‐term risk of adverse events, which can be prevented by extended anticoagulation. We compared clinical characteristics and outcomes between patients treated with 2‐year extended anticoagulation and those who ...
Romain Chopard, Ida Ehlers Albertsen, Fiona Ecarnot, Sebastien Guth, Matthieu Besutti, Nicolas Falvo, Gregory Piazza, Nicolas Meneveau   +7 more
doaj   +1 more source

Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Bleeding, Thrombosis and Vascular Biology
There is currently no established management pathway for lower extremity superficial vein thrombosis (SVT), leading to significant uncertainty among front-line providers.
Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt   +3 more
doaj   +3 more sources

A Guide to Anticoagulant Therapy [PDF]

Circulation, 1961
The physician who undertakes anticoagulant therapy tampers with one of the most important homeostatic functions of the body. In so doing, he subjects the patient to the calculated hazard of possible hemorrhage balanced against the risks of the thrombosis or embolism that he seeks to prevent or treat.
B, ALEXANDER, S, WESSLER
openaire   +2 more sources

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC

, 2011
Background: Oral anticoagulant therapy (OAT) with warfarin is the standard of stroke prevention in patients with atrial fibrillation. Approximately 30% of patients with cardioembolic strokes are on OAT at the time of symptom onset.
Förch, Christian, Waltraud Pfeilschifter, Daniel Spitzer, Pfeilschifter, Josef (Prof. Dr.), Helmuth Steinmetz, Spitzer, Daniel, Steinmetz, Helmuth, Steinmetz Helmuth, Christian Foerch, Pfeilschifter, Waltraud, Josef Pfeilschifter, Pfeilschifter Waltraud, Spitzer Daniel, Foerch Christian, Pfeilschifter Josef   +14 more
core   +1 more source

Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study

BMJ Open, 2019
Objective To investigate anticoagulant adherence and its associated factors, including demographics, clinical variables, atrial fibrillation (AF) severity, knowledge, satisfaction with services, perceived barriers, perceived benefits, symptom severity ...
Tsae-Jyy Wang, Pei-Ti Chen, Ming-Hsiung Hsieh, Ju-Chi Liu, Chieh-Yu Liu, Kwua-Yun Wang, Wen-Chun Laio   +6 more
doaj   +1 more source

Anticoagulation therapy could improve the restoration of sinus rhythm and spontaneous circulation in hospital patients with CPR

Journal of International Medical Research, 2019
Objective To analyse the role of anticoagulation therapy in cardiopulmonary resuscitation (CPR) following an in-hospital cardiac arrest. Methods This single-centre retrospective cohort study enrolled patients treated with in-hospital CPR that met the ...
Hai Wang, Zheng-Hai Bai, Jun-Hua Lv, Jiang-Li Sun, Yu Shi, Hong-Hong Pei, Zheng-Liang Zhang   +6 more
doaj   +1 more source

Legal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapy.

, 2015
Policy initiatives and technological advances enable the use of integrated shared care models of healthcare delivery whereby the focus of care is moved from the hospital to the community, and also of models where patients take increasing responsibility ...
Henry WW Potts, Potts, HW, Nicholls, JA, Jacqueline A Nicholls, David L Patterson, Patterson, DL, Bridget Coleman, Coleman, B   +7 more
core   +1 more source

The Future of Anticoagulant Therapy [PDF]

Cardiovascular Therapeutics, 2011
Major advances in the development of oral anticoagulants haveresulted in considerable progress towards the goal of safe and ef-fective oral anticoagulants that do not require frequent monitor-ing or dose adjustment, and have minimal food/drug interactionsas highlighted recently in several reports [1–7] and summarized inrecent reviews in Cardiovascular ...
openaire   +2 more sources

The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study

Clinical and Applied Thrombosis/Hemostasis, 2019
We examined the institutional variations in anticoagulation therapy for sepsis-induced disseminated intravascular coagulation (DIC) and their effects on patient outcomes.
Daisuke Kudo MD, PhD, Mineji Hayakawa MD, PhD, Hiroaki Iijima MPH, Kazuma Yamakawa MD, PhD, Shinjiro Saito MD, Shigehiko Uchino MD, PhD, Yusuke Iizuka MD, Masamitsu Sanui MD, PhD, Kohei Takimoto MD, MSc, Toshihiko Mayumi MD, PhD,   +10 more
doaj   +1 more source

Anticoagulation in the Patient with Cancer

, 2018
The association between malignant neoplasms and venous thromboembolism (VTE) is well recognized, and anticoagulation therapy is commonly administered in the oncological setting.
Mansour Khaddr, Simon Mantha, Richard Steingart, Gupta, Dipti, Soff, Gerald A., Gerald A. Soff, Salmane, Chadi, Khaddr, Mansour, Dipti Gupta, Chadi Salmane, Mantha, Simon, Steingart, Richard   +11 more
core   +1 more source